U.S. government scientists have developed a new phase of matter dubbed 'half ice, half fire,' which unites opposing electron ...

Pfizer and Arvinas’ estrogen receptor (ER) degrader has failed a key part of its first phase 3 test, although the companies have pointed to success in a subpopulation to suggest the therapy ...